HepCom: impact of co-morbidities on the final success of direct antiviral agents therapy in hepatitis C

Autor:	A. Ortega, José Miguel Rosales, M. Diago, Xavier Forns, Martin Bonacci, R. Quiles, Javier Crespo, Isabel Carmona, M. de la Mata, M. Maraver, JM Salmerón, C.J. Maté, J.M. Navarro, Nieves Palomo, F.J. Serrano, G. Ontanilla, P. Cordero, Javier Ampuero, R.J. Andrade, Marcela A. Hernández, J.L. Calleja, M. Buti, Susana Llerena, Manuel Romero-Gómez, Juan Manuel Pascasio, Juan José Urquijo, Blanca Figueruela
Rok vydání:	2017
Předmět:	medicine.medical_specialty Hepatology business.industry Internal medicine medicine Co morbidity Hepatitis C medicine.disease business Virology
Zdroj:	Journal of Hepatology. 66:S514-S515
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(17)31431-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3b93220071053004cdc8a6c718c216c9 https://doi.org/10.1016/s0168-8278(17)31431-9 Zobrazit plný text záznamu Full Text from ScienceDirect